Treatment for Hypomagnesemia
The first-line treatment for hypomagnesemia is oral magnesium supplementation for mild cases (serum Mg 0.5-0.7 mmol/L), while parenteral magnesium sulfate is indicated for severe cases (serum Mg <0.5 mmol/L) or symptomatic patients. 1, 2
Assessment and Diagnosis
- Hypomagnesemia is common, occurring in 11% of hospitalized patients and up to 65% of critically ill patients 3
- Serum magnesium levels below 1.8 mg/dL (<0.74 mmol/L) define hypomagnesemia 4
- Symptoms typically appear when serum magnesium falls below 1.2 mg/dL and may include neuromuscular irritability, tetany, tremors, seizures, and cardiac arrhythmias 4, 2
- Measure fractional excretion of magnesium to determine if hypomagnesemia is due to renal losses (>2%) or gastrointestinal losses (<2%) 4
Treatment Algorithm
Oral Supplementation
- For mild hypomagnesemia (serum Mg 0.5-0.7 mmol/L) without symptoms:
- Start with the recommended daily allowance: 320 mg for women and 420 mg for men 1
- Magnesium oxide at doses of 12-24 mmol daily (approximately 480-960 mg elemental magnesium) 1, 2
- Administer at night when intestinal transit is slowest to improve absorption 1
- Liquid or dissolvable forms are generally better tolerated than pills 1
Parenteral Supplementation
- For severe hypomagnesemia (serum Mg <0.5 mmol/L) or symptomatic patients:
- Intravenous magnesium sulfate is indicated 5
- For mild deficiency: 1 g (8.12 mEq) IM every six hours for four doses 5
- For severe hypomagnesemia: up to 250 mg/kg IM within four hours, or 5 g (40 mEq) IV infused over three hours 5
- IV injection rate should not exceed 150 mg/minute 5
- Solutions for IV infusion must be diluted to a concentration of 20% or less prior to administration 5
Special Considerations
Renal Impairment
- Avoid magnesium supplementation in patients with renal insufficiency due to risk of hypermagnesemia 1, 3
- In patients with renal insufficiency, maximum dosage should not exceed 20 grams/48 hours with frequent monitoring of serum magnesium levels 5
Associated Electrolyte Abnormalities
- Correct hypomagnesemia before addressing hypokalemia and hypocalcemia, as these conditions may be refractory to treatment until magnesium is repleted 1, 6
- Monitor potassium and calcium levels during magnesium replacement 2
Specific Clinical Scenarios
In patients with short bowel syndrome or high-output stomas:
For patients on continuous renal replacement therapy:
Monitoring and Follow-up
- Monitor serum magnesium levels regularly during treatment 1
- Observe for resolution of clinical symptoms 2
- Watch for side effects of magnesium supplementation, including diarrhea, abdominal distension, and gastrointestinal intolerance 1
- In severe cases, monitor for signs of magnesium toxicity, including hypotension, respiratory depression, and loss of deep tendon reflexes 6
Common Pitfalls
- Failing to recognize that serum magnesium can be normal despite intracellular magnesium depletion 6
- Not addressing underlying causes of magnesium deficiency 4
- Overlooking the need to correct water and sodium depletion before magnesium supplementation in patients with gastrointestinal losses 1, 2
- Forgetting that hypokalemia and hypocalcemia may be refractory to treatment until hypomagnesemia is corrected 1, 6